Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · CIK 714256 · FYE Dec 31 · Prices AT CLOSE 2026-08-21 (USD) Last $34.45 · Day +0.61% · Mkt cap $317M · 1Y +12.9% · Off 52W high −4.2% · Vol (1Y) 62.2% Price2023-08-21 → 2026-08-21 SMTI close: $39.0 on 2023-08-21 to $34.5 on 2026-08-21. Split-adj closes · 240 of 2,538 · price returnⓘ At a glance | Short interest2.4% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)−6.25% | | Top-10 13F concentration70.5% | | Next report (est.)2026-11-10 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$109.8M | | Earnings (TTM)-$32.0M | | ROE−165.7% | | Net margin−36.4% | | Debt / equity7.74× | | Total debt / EBITDA4.09× | | Sales growth 3Y31.0% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+47.5% | | 1Y+12.9% | | 3Y−11.7% | | 5Y+2.8% | | 10Y+589.0% | | Since incept. (ann.)+21.0% |
Total return · from 2016-07-11ⓘ Risk | Ann. volatility (1Y)62.2% | | Ann. volatility (3Y)57.2% | | Sharpe (1Y)0.50 | | Sharpe (3Y)0.21 | | Max drawdown (1Y)−54.3% | | Max drawdown (3Y)−60.7% | | Beta (3Y vs SPY)1.54 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 228,767 | $4M | 2.50% | +7.0% | | VANGUARD CAPITAL MANAGEMENT LLC | 151,367 | $3M | 1.65% | new | | Stonebridge Wealth Management, LLC | 136,899 | $2M | 1.49% | +1.5% | | ROYAL BANK OF CANADA | 131,389 | $2M | 1.43% | +11.7% | | GEODE CAPITAL MANAGEMENT, LLC | 85,662 | $1M | 0.93% | +8.4% | | MARSHALL WACE, LLP | 76,282 | $1M | 0.83% | +56.9% | | Squarepoint Ops LLC | 73,607 | $1M | 0.80% | +50.4% | | RENAISSANCE TECHNOLOGIES LLC | 64,680 | $1M | 0.71% | +72.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-11 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-11 | −$0.05 | — | $28.1M | +9.0% | | 2026-03-31 | 2026-05-11 | $0.05 | — | $27.8M | +18.6% | | 2025-12-31 | 2026-03-24 | −$0.32 | — | $27.5M | +4.7% | | 2025-09-30 | 2025-11-12 | −$3.40 | — | $26.3M | +21.5% |
As-reported XBRL · next 2026-11-10 est.ⓘ Segment mixFY2025 (ended Dec 2025) Soft Tissue Repair Products 89% · Bone Fusion Products 11% product & service · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
